C12Y 304/23012
Nepenthesin
Official title: Nepenthesin (3.4.23.12)
C12Y304/23012 (Nepenthesin) appears on 11 US grants and 13 published applications in this corpus.
Search patents in C12Y- Granted patents
- 11
- Published applications
- 13
- Assignees
- 3
- Inventors
- 13
- Latest grant
- 15 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 2 |
| 2015 | 1 | 2 |
| 2016 | 0 | 1 |
| 2017 | 2 | 2 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 2 |
| 2021 | 2 | 3 |
| 2022 | 0 | 0 |
| 2023 | 4 | 0 |
By publication year.
Recent patents
- Compositions and methods for treating gluten intolerance and disorders arising therefrom15 Aug 2023US 11,723,960 B2Codexis, Inc.
- Treatment of gluten intolerance and related conditions15 Aug 2023US 11,725,198 B2Codexis, Inc.
- Compositions and methods for treating gluten intolerance and disorders arising therefrom18 Jul 2023US 11,701,411 B2Codexis, Inc.
- Nepenthesin-1 derived resistance to fungal pathogens in major crop plants10 Jan 2023US 11,549,124 B2Aarhus Universitet
- Treatment of gluten intolerance and related conditions20 Apr 2021US 10,982,201 B2Codexis, Inc.
- Treatment of gluten intolerance and related conditions29 Jul 2021US 2021/0230569 A1Codexis, Inc.
- Compositions and methods for treating gluten intolerance and disorders arising therefrom22 Jul 2021US 2021/0220451 A1Codexis, Inc.
- Compositions and methods for treating gluten intolerance and disorders arising therefrom1 Apr 2021US 2021/0093699 A1Codexis, Inc.
- Nepenthesin-1 derived resistance to fungal pathogens in major crop plants15 Oct 2020US 2020/0325490 A1Aarhus Universitet
- Treatment of gluten intolerance and related conditions6 Feb 2020US 2020/0040322 A1Nepetx, LLC
Most cited
By later US patents
- Treatment of gluten intolerance and related conditions9US 9,005,610 B2Nepetx, LLC · 2015
- Treatment of gluten intolerance and related conditions5US 9,745,565 B2Nepetx, LLC · 2017
- Treatment of gluten intolerance and related conditions3US 9,623,092 B2Nepetx, LLC · 2017
- Treatment of gluten intolerance and related conditions1US 10,266,818 B2Nepetx, LLC · 2019
- Treatment of gluten intolerance and related conditions1US 10,982,201 B2Codexis, Inc. · 2021